PDIA3 and BACE1

Number of citations of the paper that reports this interaction (PMID 15606899)
12

Data Source:
HPRD (two hybrid)

		PDIA3	BACE1
Gene Name		protein disulfide isomerase family A, member 3	beta-site APP-cleaving enzyme 1
Image
Gene Ontology Annotations	Cellular Component	Nucleus Endoplasmic Reticulum Endoplasmic Reticulum Lumen Smooth Endoplasmic Reticulum Focal Adhesion Cell Surface Melanosome Extracellular Vesicular Exosome	Endosome Late Endosome Multivesicular Body Endoplasmic Reticulum Golgi Apparatus Trans-Golgi Network Plasma Membrane Integral Component Of Plasma Membrane Cell Surface Integral Component Of Membrane Axon Cytoplasmic Vesicle Membrane
	Molecular Function	Protein Disulfide Isomerase Activity Cysteine-type Endopeptidase Activity Phospholipase C Activity Protein Binding Poly(A) RNA Binding	Beta-amyloid Binding Aspartic-type Endopeptidase Activity Protein Binding Beta-aspartyl-peptidase Activity Enzyme Binding
	Biological Process	Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I, TAP-dependent Protein Folding Proteolysis Protein Import Into Nucleus Protein Retention In ER Lumen Signal Transduction Protein N-linked Glycosylation Via Asparagine Response To Endoplasmic Reticulum Stress Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I Post-translational Protein Modification Cellular Protein Metabolic Process Cell Redox Homeostasis Positive Regulation Of Extrinsic Apoptotic Signaling Pathway	Proteolysis Membrane Protein Ectodomain Proteolysis Beta-amyloid Metabolic Process
Pathways		Diseases of glycosylation Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS) Defective MGAT2 causes MGAT2-CDG (CDG-2a) Defective ALG1 causes ALG1-CDG (CDG-1k) Antigen Presentation: Folding, assembly and peptide loading of class I MHC Defective MOGS causes MOGS-CDG (CDG-2b) Defective ALG9 causes ALG9-CDG (CDG-1l) Defective MAN1B1 causes MRT15 Class I MHC mediated antigen processing & presentation N-glycan trimming in the ER and Calnexin/Calreticulin cycle Defective ALG11 causes ALG11-CDG (CDG-1p) Defective ALG2 causes ALG2-CDG (CDG-1i) Post-translational protein modification Defective ALG3 causes ALG3-CDG (CDG-1d) Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2 Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) Defective RFT1 causes RFT1-CDG (CDG-1n) Defective ALG6 causes ALG6-CDG (CDG-1c) Asparagine N-linked glycosylation Defective ALG8 causes ALG8-CDG (CDG-1h) Defective MPDU1 causes MPDU1-CDG (CDG-1f) Defective ALG12 causes ALG12-CDG (CDG-1g) Antigen processing-Cross presentation ER-Phagosome pathway Diseases associated with N-glycosylation of proteins Adaptive Immune System Calnexin/calreticulin cycle
Drugs			MMI-175 N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide 4-(4-FLUOROBENZYL)PIPERIDINE N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide 6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE 6-[2-(3\'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE N~3~-BENZYLPYRIDINE-2,3-DIAMINE N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE 4-(2-aminoethyl)-2-cyclohexylphenol 4-(2-aminoethyl)-2-ethylphenol 4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine (6R)-2-amino-6-[2-(3\'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one 2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one (2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide (2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide (2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide (6S)-2-amino-6-(3\'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE 3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE
Diseases
GWAS			Cardiovascular disease risk factors ( 21779381)
Protein-Protein Interactions		15 interactors: APP BACE1 CALR CANX ERO1L ERP27 GYPC HLA-A IFNG MDM2 SLC12A3 SLC2A1 STAT3 SUMO4 TAP1	22 interactors: APP ATP1B1 BRI3 CMPK1 CSNK1D FBXO2 FURIN GGA1 GGA2 GGA3 ITM2C KHSRP LRP1 MMP2 NCSTN PCSK9 PDIA3 PLSCR1 PSAP PSEN1 RANBP9 SELPLG
Entrez ID		2923	23621
HPRD ID		03625	07255
Ensembl ID		ENSG00000167004	ENSG00000186318
Uniprot IDs		G5EA52 P30101	B7Z3K2 B7Z3Z4 P56817 Q5W9H2
PDB IDs		2ALB 2DMM 2H8L 3F8U	1FKN 1M4H 1PY1 1SGZ 1TQF 1UJJ 1UJK 1W50 1W51 1XN2 1XN3 1XS7 1YM2 1YM4 2B8L 2B8V 2F3E 2F3F 2FDP 2G94 2HIZ 2HM1 2IQG 2IRZ 2IS0 2NTR 2OAH 2OF0 2OHK 2OHL 2OHM 2OHN 2OHP 2OHQ 2OHR 2OHS 2OHT 2OHU 2P4J 2P83 2P8H 2PH6 2PH8 2Q11 2Q15 2QK5 2QMD 2QMF 2QMG 2QP8 2QU2 2QU3 2QZK 2QZL 2VA5 2VA6 2VA7 2VIE 2VIJ 2VIY 2VIZ 2VJ6 2VJ7 2VJ9 2VKM 2VNM 2VNN 2WEZ 2WF0 2WF1 2WF2 2WF3 2WF4 2WJO 2XFI 2XFJ 2XFK 2ZDZ 2ZE1 2ZHR 2ZHS 2ZHT 2ZHU 2ZHV 2ZJH 2ZJI 2ZJJ 2ZJK 2ZJL 2ZJM 2ZJN 3BRA 3BUF 3BUG 3BUH 3CIB 3CIC 3CID 3CKP 3CKR 3DM6 3DUY 3DV1 3DV5 3EXO 3FKT 3H0B 3HVG 3HW1 3I25 3IGB 3IN3 3IN4 3IND 3INE 3INF 3INH 3IVH 3IVI 3IXJ 3IXK 3K5C 3K5D 3K5F 3K5G 3KMX 3KMY 3KN0 3KYR 3L38 3L3A 3L58 3L59 3L5B 3L5C 3L5D 3L5E 3L5F 3LHG 3LNK 3LPI 3LPJ 3LPK 3MSJ 3MSK 3MSL 3N4L 3NSH 3OHF 3OHH 3OOZ 3PI5 3QBH 3QI1 3R1G 3R2F 3RSV 3RSX 3RTH 3RTM 3RTN 3RU1 3RVI 3S2O 3S7L 3S7M 3SKF 3SKG 3TPJ 3TPL 3TPP 3TPR 3U6A 3UDH 3UDJ 3UDK 3UDM 3UDN 3UDP 3UDQ 3UDR 3UDY 3UFL 3UQP 3UQR 3UQU 3UQW 3UQX 3VEU 3VF3 3VG1 3VV6 3VV7 3VV8 3WB4 3WB5 3ZMG 3ZOV 4ACU 4ACX 4AZY 4B00 4B05 4B0Q 4B1C 4B1D 4B1E 4B70 4B72 4B77 4B78 4BEK 4BFD 4D83 4D85 4D88 4D89 4D8C 4DH6 4DI2 4DJU 4DJV 4DJW 4DJX 4DJY 4DPF 4DPI 4DUS 4DV9 4DVF 4EWO 4EXG 4FCO 4FGX 4FM7 4FM8 4FRI 4FRJ 4FRK 4FRS 4FS4 4FSE 4FSL 4GID 4GMI 4H1E 4H3F 4H3G 4H3I 4H3J 4HA5 4HZT 4I0E 4I0F 4I0G 4I0H 4I0J 4I0Z 4I10 4I11 4I12 4I1C 4J0T 4J0V 4J0Y 4J0Z 4J17 4J1C 4J1E 4J1F 4J1H 4J1I 4J1K 4JOO 4JP9 4JPC 4JPE 4K8S 4K9H 4KE0 4KE1 4L7G 4L7H 4L7J 4LC7 4LXA 4LXK 4LXM
Enriched GO Terms of Interacting Partners?		Antigen Processing And Presentation Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I Protein Localization To Nucleus Chaperone-mediated Protein Folding Antigen Processing And Presentation Of Peptide Antigen Cellular Localization Response To Stress Protein Maturation By Protein Folding Endoplasmic Reticulum Unfolded Protein Response Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I, TAP-dependent Cellular Response To Unfolded Protein Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I Cytoplasmic Transport Negative Regulation Of Cell Development ER-nucleus Signaling Pathway Cellular Response To Topologically Incorrect Protein Antigen Processing And Presentation Of Endogenous Antigen Establishment Of Localization In Cell Defense Response Homeostatic Process Response To Unfolded Protein Immune System Process Chemical Homeostasis Establishment Of Protein Localization Intracellular Transport Response To Endoplasmic Reticulum Stress Response To Drug Protein Localization To Organelle Viral Process Intracellular Receptor Signaling Pathway Response To Estrogen Protein Maturation Transport Cellular Response To Organic Substance Protein Localization Nucleocytoplasmic Transport Nuclear Transport Positive Regulation Of Mitotic Cell Cycle Phase Transition Protein Folding Regulation Of Neurogenesis Positive Regulation Of Cell Cycle Positive Regulation Of Cell Cycle Phase Transition Negative Regulation Of Neurogenesis Cellular Calcium Ion Homeostasis Positive Regulation Of Proteolysis Negative Regulation Of Cell Differentiation Cellular Protein Localization Calcium Ion Homeostasis Peptide Antigen Assembly With MHC Class I Protein Complex	Neuron Differentiation Establishment Of Localization In Cell Positive Regulation Of Apoptotic Process Positive Regulation Of Programmed Cell Death Smooth Endoplasmic Reticulum Calcium Ion Homeostasis Positive Regulation Of Cell Death Regulation Of Protein Catabolic Process Positive Regulation Of Protein Catabolic Process Extracellular Matrix Disassembly Protein Processing Transport Cellular Localization Intracellular Transport Generation Of Neurons Positive Regulation Of Proteolysis Notch Signaling Pathway Regulation Of Low-density Lipoprotein Particle Receptor Catabolic Process Neurogenesis Regulation Of Signal Transduction Extracellular Matrix Organization Extracellular Structure Organization Protein Transport Vesicle-mediated Transport Amyloid Precursor Protein Catabolic Process Cell Activation Establishment Of Protein Localization Negative Regulation Of Neuron Differentiation Regulation Of Apoptotic Process Regulation Of Signaling Blood Coagulation Hemostasis Regulation Of Cell Death Positive Regulation Of Extrinsic Apoptotic Signaling Pathway Regulation Of Protein Metabolic Process Positive Regulation Of Metabolic Process Positive Regulation Of Protein Metabolic Process Locomotion Amyloid Precursor Protein Metabolic Process Nervous System Development Intracellular Protein Transport Negative Regulation Of Neurogenesis Response To External Stimulus Membrane Protein Ectodomain Proteolysis Beta-amyloid Metabolic Process Notch Receptor Processing Regulation Of Body Fluid Levels Regulation Of Receptor Activity Cholesterol Metabolic Process Neuron Development Negative Regulation Of Neuron Projection Development
Tagcloud ?		calnexin calreticulin catalysed desirable disulphide erdj5 erp44 erp57 erp72 grp78 immunocytochemical immunogens immunolocalization infective isomerase orthologues pdia10 pdia19 pdia2 pdia4 pdis spiralis thioredoxin tmx1 tmx2 tmx3 trichinella trimerization	abca1 administrated amplitudes aspartic bax erg excitotoxicity gcl injection inl inner intravitreal lxr lxralpha lxrbeta lxrs neuroprotective neurotoxicity nevertheless nmda orally preserved protects retinal speculate to90 to901317 upregulated wave
Tagcloud (Difference) ?		calnexin calreticulin catalysed desirable disulphide erdj5 erp44 erp57 erp72 grp78 immunocytochemical immunogens immunolocalization infective isomerase orthologues pdia10 pdia19 pdia2 pdia4 pdis spiralis thioredoxin tmx1 tmx2 tmx3 trichinella trimerization	abca1 administrated amplitudes aspartic bax erg excitotoxicity gcl injection inl inner intravitreal lxr lxralpha lxrbeta lxrs neuroprotective neurotoxicity nevertheless nmda orally preserved protects retinal speculate to90 to901317 upregulated wave
Tagcloud (Intersection) ?